Medication barriers and anti-hypertensive medication adherence: the moderating role of locus of control. - Wikidata - wikimedia - TriplyDB

Medication barriers and anti-hypertensive medication adherence: the moderating role of locus of control.

Medication barriers and anti-hypertensive medication adherence: the moderating role of locus of control.

http://www.wikidata.org/entity/Q40266181

about

Applying qualitative methods in developing a culturally tailored workbook for black patients with hypertension.Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.Autonomous regulation and locus of control as predictors of antiretroviral medication adherence.The causal representation of outpatients with Crohn's disease: is there a link between psychological distress and clinical disease activity?Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies.Locus of control and anti-hypertensive medication adherence in Ghana.Cultural Beliefs Underlying Medication Adherence in People of Chinese Descent in the United States.Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence.Fatalism and hypertension prevalence, awareness, treatment and control in US Hispanics/Latinos: results from HCHS/SOL Sociocultural Ancillary Study.Views on treatment necessity, harm, and benefits in patients using statins.Medication adherence in Greek hemodialysis patients: the contribution of depression and health cognitions.Use of the Multidimensional Health Locus of Control to Predict Information-Seeking Behaviors and Health-Related Needs in Pregnant Women and Caregivers.

P2860

Q30434685-A8A113C0-CE2E-45AB-9554-8D16624935DF Q33578701-BBA86BE1-9E0A-4EF1-B689-BC35D663F6A1 Q37323615-62B1CF5F-D480-4CBD-9E26-B8606BD47622 Q37448259-5852A713-8EF3-4406-B6D3-2505F65122F8 Q37483643-2B8D0120-4E16-4F9B-AD10-FD2DD9BA15CC Q37624087-D9BF4737-2377-40FA-A398-774F9058907D Q41285039-A2CE5F5B-3992-415B-BCF0-527061ADD832 Q42685293-57FD96E7-36A7-4C64-8DE3-597E159BF2AE Q46066078-55802E83-EE54-493C-9811-D141A4C95958 Q46764821-3765FDD3-E085-4290-914F-FE1E123DEAD9 Q48715722-1DD5322B-811A-4446-8B5E-ADAB831C765E Q54936025-0B4FFE59-CD5F-4DC7-837D-3CAC87460A62

P2860

Medication barriers and anti-hypertensive medication adherence: the moderating role of locus of control.

http://www.wikidata.org/entity/Q40266181

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Medication barriers and anti-h ...... ting role of locus of control.

@en

type

label

Medication barriers and anti-h ...... ting role of locus of control.

@en

prefLabel

Medication barriers and anti-h ...... ting role of locus of control.

@en

P1433

Q40266181-F911E95B-53F3-4C23-A8CF-04CF014503AA

P1476

Q40266181-D315E4A4-D3C5-45EB-A5EB-57E106491985

P2093

Q40266181-188C8E62-B366-4995-86DF-61A786E09651

Q40266181-A9F5AE02-963A-4EE6-9ACF-38662BF347CD

Q40266181-B841F33E-50E9-44A7-8B00-C6356491C395

P2860

Q40266181-1ECA883F-2352-4AAB-BBAE-8703D628221F

Q40266181-2F83D23A-0F77-4EF6-B3D9-328B01795EA5

Q40266181-3705BDEF-0BF1-4880-A7C7-C7190A07801F

Q40266181-3C1FE172-F8BA-4A7B-8C58-C9564E39CD88

Q40266181-3F5C2842-0B1E-41C0-9D49-BD9525CD92A6

Q40266181-4654FFD6-D5FA-43BC-BA69-67A611354B32

Q40266181-4A4CFEE6-AE1D-4B33-B83D-7D623B49891A

Q40266181-5613FD12-ED5E-4E5B-AAC2-5C7935AAA0B4

Q40266181-7AC8663C-EEAE-4B9C-9C6E-1FEC86F0D440

Q40266181-8131B73D-6C20-4860-8D38-81ED45DE2CA6

P304

Q40266181-086E5BBC-5781-4762-959C-20A6C513D678

P31

Q40266181-6FBF0060-6ED9-4608-9E39-2CD32C3486CC

P356

Q40266181-C29CE424-F456-49F4-B8A6-60C0ACBA36B8

P433

Q40266181-FC733680-ADFE-4B6F-987F-1602658C2910

P478

Q40266181-BD1F1D21-5A4C-4D1D-82FD-68CB64CA5D82

P50

Q40266181-98B4203F-7BD6-4E9E-80F1-250C74C10CD5

P577

Q40266181-6B9F33E7-4254-4A32-B8F2-9A6B6EA8C197

P698

Q40266181-B8CEAEA1-C74A-4488-A16D-A8FF026A83AB

P356

14786430500228580

P1433

Psychology, Health and Medicine

P1476

Medication barriers and anti-h ...... ting role of locus of control.

@en

P2093

Eugene Z Oddone

http://www.w3.org/2001/XMLSchema#string

Tantina B Hong

http://www.w3.org/2001/XMLSchema#string

Tara K Dudley

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations

The Health Belief Model: A Decade Later

Hypertension and current issues in compliance and patient outcomes.

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Treatment adherence in chronic disease.

Psychosocial risk factors and mortality: a prospective study with special focus on social support, social participation, and locus of control in Norway

Patient compliance in hypertension: role of illness perceptions and treatment beliefs.

Compliance with tricyclic antidepressants: the value of four different methods of assessment

Improving compliance and increasing control of hypertension: needs of special hypertensive populations.

P304

20-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14786430500228580

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Hayden B Bosworth

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17129892

http://www.w3.org/2001/XMLSchema#string